Arrieta, O., Lara-Mejía, L., Rios-Garcia, E., Caballé-Perez, E., Cabrera-Miranda, L., Ramos-Ramírez, M., Dávila-Dupont, D., Cardona, A. F., Cruz-Rico, G., Remon, J., Garcilazo-Reyes, A., Rosell, R. (2025). Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial. Nature Communications. https://doi.org/10.1038/s41467-025-67648-x